Trial Profile
Phase II THN101-201 trial for Neuropathic pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2018
Price :
$35
*
At a glance
- Drugs Amitriptyline/mefloquine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 25 Oct 2018 New trial record
- 15 Oct 2018 According to Theranexus media releaase, study is epected to start in the first half of 2019.